摘要
目的快速掌握注射用红花黄色素的研究内容和研究热点,并能较准确地推测其研究趋势。方法通过检索中国知网(CNKI)及Webs of Science两大数据库关于注射用红花黄色素的相关报道,并利用文献计量学手段及CiteSpace5.7.R5软件呈现出相关文献的作者、机构、关键词等信息可视化知识图谱。结果检索到注射用红花黄色素研究的国内文献190篇,国外文献仅26篇,分析得知,徐露是该研究国内发文量最多的作者,并形成稳定的核心团队;国内各机构间研究的发文量基本接近,且不存在合作关系。结论注射用红花黄色素的临床疗效及不良反应是目前国内的研究热点。
Objective To quickly grasp research contents and focuses of safflower yellow for injection,and to accurately predict its research trend.Methods The related reports of safflower yellow for injection were searched from CNKI and Webs of Science,and bibliometrics and CiteSpace5.7.R5 software were utilized to generate a visual knowledge map,presenting information such as authors,institutions,and key words.Results There were 190 pieces of domestic literature and only 26 pieces of foreign literature related to safflower yellow for injection.According to the analyses,Xu Lu who had a stable core research team was the most prolific author in the research on safflower yellow for injection in China.The volume of publications for research was largely similar among institutions in China and there were no collaborative relationships.Conclusion The clinical efficacy and the adverse effects of safflower yellow for injection are currently a hot research topic of research in China.
作者
张雅筠
康永
倪艳
程玉钏
郝旭亮
ZHANG Yajun;KANG Yong;NI Yan;CHENG Yuchuan;HAO Xuliang(Institute of Traditional Chinese Medicine Prescription,Shanxi Academy of Traditional Chinese Medicine,Shanxi,Taiyuan 030012,China;The Hospital of Shanxi University of Chinese Medicine,Shanxi,Taiyuan 030024,China)
出处
《中国医药科学》
2022年第3期67-70,共4页
China Medicine And Pharmacy
基金
山西省卫生健康委员会重点实验室建设计划(2020SYS09)。